| Literature DB >> 20621725 |
Mauro Angiolini1, Patrizia Banfi, Elena Casale, Francesco Casuscelli, Claudio Fiorelli, Maria B Saccardo, Marco Silvagni, Fabio Zuccotto.
Abstract
In this Letter is described the structure-based design of potent dihydro-pyrazoloquinazolines as PDK1 inhibitors. Starting from low potency HTS hits with the aid of X-ray crystallography and modeling, a medicinal chemistry activity was carried out to improve potency versus PDK1 and selectivity versus CDK2 protein kinase. 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20621725 DOI: 10.1016/j.bmcl.2010.05.070
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823